Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.

Samuel, L M; Harvey, V J; Mitchell, P L; Thompson, P I; Mak, D; Melville, P; Evans, B D

Samuel, L M; Harvey, V J; Mitchell, P L; Thompson, P I; Mak, D; Melville, P; Evans, B D.

Affiliation

Samuel LM; Department of Clinical Oncology, Auckland Hospital, New Zealand.

Eur J Cancer ; 30A(14): 2054-6, 1994.

Article in En | MEDLINE | ID: mdl-7857702

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Melanoma/drug therapy; Skin Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Female; Humans; Lomustine/administration & dosage; Male; Middle Aged; Neoplasm Metastasis; Neutropenia/chemically induced; Procarbazine/administration & dosage; Thrombocytopenia/chemically induced; Treatment Outcome; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Melanoma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 1994 Document type: Article Affiliation country: New Zealand

Search on Google

Add to My VHL

XML

PubMed Links